111

SCHOTT PHARMA AG & CO. KGAA

No trades
See on Supercharts

1SXP fundamentals

An in-depth look to SCHOTT PHARMA AG & CO. KGAA operating, investing, and financing activities

1SXP free cash flow for Q3 24 is 34.05 M EUR. For 2023, 1SXP free cash flow was 6.18 M EUR and operating cash flow was 181.65 M EUR.

Q4 '22
Q1 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q4 '22
Q1 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM
Free cash flowYoY growth